Browse the evidence

Both the narrow pyramid (NPR) and wide pyramid (WPR) resistance training systems significantly improved bioimpedance vector analysis (BIVA) patterns compared to the control group (CON) after eight weeks.

Resistance training can effectively improve body composition metrics in older women.

The wide pyramid resistance training system (WPR) resulted in a greater increase in phase angle (PhA) compared to the narrow pyramid (NPR) and control (CON) groups.

Utilizing a wide pyramid training approach may enhance cellular health indicators in older women.

HMB may have a small, positive impact on fat-free mass (FFM) in athletes when protein intake is suboptimal (<1.6 g·kg-1·d-1).

Athletes with low protein intake may benefit from HMB supplementation for improving muscle mass.

GLP-1 receptor agonists have beneficial effects on atherosclerosis and cardiovascular disease.

Practitioners may consider GLP-1 receptor agonists as a treatment option for improving cardiovascular health in patients with obesity and type 2 diabetes.

MyoPS increased above REST in both untrained and trained states, with a greater increase in males.

Males may experience a greater increase in muscle protein synthesis following resistance training.

Environmental factors such as meal schedule, food contents, type of exercise, and sleep deprivation influence gut hormones and appetite.

Practitioners should consider these environmental factors when addressing appetite and weight management.

Both low velocity loss (LVL) and high velocity loss (HVL) resistance training programs resulted in similar increases in 1 repetition maximum (1 RM), maximal voluntary contraction (MVC), power output, and muscle thickness.

Practitioners can use either LVL or HVL resistance training to achieve similar strength and hypertrophy outcomes.

The study utilized a within person, between leg design to compare the effects of different velocity loss thresholds.

The study design enhances the reliability of the results.

Obesity is associated with and likely has a direct causal role in the onset, progression and severity of chronic kidney disease.

Practitioners should consider the impact of obesity on chronic kidney disease management.

Obesity and chronic kidney disease place a significant burden on the health care delivery system.

Healthcare providers should be aware of the systemic impacts of obesity and CKD.

Metabolic adaptation plays a relevant role in the management of obesity and human weight loss.

Practitioners should consider metabolic adaptation when designing weight loss interventions.

Drop set training may be an effective strategy to enhance muscular adaptations.

Practitioners may consider incorporating drop set training to potentially enhance muscle growth.

N-3 PUFA had no added benefit on muscle protein synthesis (MPS) but showed a trend towards increased absolute synthesis rates (ASR) during weeks 4–6 of resistance exercise training.

While n-3 PUFA may not significantly enhance MPS, it could still support muscle adaptation during resistance training.

Greater improvement in blood sugar control was associated with better cognitive scores.

Improving blood sugar control may enhance cognitive function in older adults with diabetes.

Eccentric duration was significantly and inversely correlated with average concentric velocity (ACV) at 60% (r = −0.408, p = 0.004) and 80% (r = −0.477, p = 0.001) of 1RM squat.

Practitioners should consider the duration of the eccentric phase to optimize concentric performance.

GLP-1 receptor agonists (GLP-1 RAs) may improve obstructive sleep apnea (OSA) symptoms by reducing fat deposition around the upper airway and decreasing systemic inflammation.

Practitioners may consider GLP-1 RAs as a potential treatment option for improving OSA symptoms in obese patients.

GLP-1 RAs may enhance traditional OSA treatments, offering an integrated approach targeting the root cause of obesity in OSA.

Practitioners should consider integrating GLP-1 RAs into OSA management strategies.

GLP-1 RAs may provide benefits for other obesity-related comorbidities, including hypertension and cardiovascular disease.

Practitioners should be aware of the potential for GLP-1 RAs to address comorbidities in obese OSA patients.

Semaglutide reduced HbA1c by 0.46% of total hemoglobin in SGA-treated patients with schizophrenia, prediabetes, and obesity.

Semaglutide may be an effective treatment option for managing blood glucose levels in this patient population.

Semaglutide improved physical quality of life by 3.75 points on the SF-36v2.

Semaglutide may enhance physical quality of life for patients in this group.

GLP-1RA users had a lower risk of stroke (HR, 0.81; 95% CI, 0.70-0.93) compared to other antidiabetic drug users.

Practitioners may consider GLP-1RAs as a treatment option for reducing stroke risk in this population.

GLP-1RA users had a lower risk of all-cause mortality (HR, 0.70; 95% CI, 0.63-0.78) compared to other antidiabetic drug users.

Practitioners may consider GLP-1RAs as a treatment option for reducing all-cause mortality in this population.

High school students in Philadelphia experienced reductions in soda consumption due to sugar-sweetened beverage taxes.

Implementing sugar-sweetened beverage taxes may effectively reduce soda consumption among adolescents.

Average body mass index (BMI) among high school students decreased in Philadelphia, San Francisco, and Oakland following the implementation of sugar-sweetened beverage taxes.

Sugar-sweetened beverage taxes may contribute to lower BMI in adolescents.